is tirzepatide a dual agonist Metabolic therapy evolving faster than many clinics realize. In Episode 1 of Drug Decode, we break down: Afrezza® – needle-free prandial insulin Semaglutide – CV-proven GLP-1 therapy – incretin Tirzepatide 30mg Dual GLP-1 &

White blood cell count (WBC), oxidative burst (ROS activity), total serum protein (TP), total immunoglobulin (TI), and PA were measured in blood and serum to evaluate the immune response

P., and Rienzi, A

Temperature cycling, going from cold to warm to cold again, is also damaging

Read the study here

Neurotrophic peptides (Semax, Cerebrolysin) that create the biological conditions for repair could follow once the acute danger has passed

For comparison, tirzepatide (Mounjaro, Zepbound) has a slightly lower constipation rate at 14-17% across doses, possibly because the GIP receptor component partially counteracts GLP-1's motility effects in some patients